Business Context and Reporting Period
This Form 8-K, dated August 30, 2022, reports that East Resources Acquisition Company ("ERES"), a special purpose acquisition company (SPAC), entered into a definitive Merger Agreement with Longevity Market Assets, LLC ("LMA") and Abacus Settlements, LLC ("Abacus"). The transaction involves the merger of LMA and Abacus into ERES, creating a publicly traded entity focused on the life settlement industry. The filing details the terms of the merger, support agreements, and conditions precedent to closing.
Key Financial Metrics and Transaction Terms
- Aggregate Consideration: Approximately $618.0 million in total value to be paid to the members of LMA and Abacus.
- Consideration Structure: Payment will be made primarily in newly issued shares of ERES Class A common stock, valued at $10.00 per share.
- Cash Component: To the extent Aggregate Transaction Proceeds exceed $200.0 million, Company Members may elect to receive up to $20.0 million in cash on a pro rata basis.
- Minimum Cash Requirement: A condition to closing requires Aggregate Transaction Proceeds plus any Sponsor PIK Note to equal or exceed $1,000,000.
- Net Tangible Assets: ERES must maintain at least $5,000,001 in net tangible assets immediately after the effective time of the transaction.
- Warrant Exercise Price: Existing warrants are exercisable for one share of Class A common stock at $11.50 per share.
Material Changes and Agreements
The primary material change is the execution of the Merger Agreement, which alters the corporate structure of ERES from a SPAC holding cash in a Trust Account to an operating company in the life settlement sector. Key ancillary agreements include:
- Sponsor Support Agreement: The Sponsor (East Sponsor, LLC) agreed to vote in favor of the transaction, waive redemption rights, and lock up 15% of shares for 180 days and 85% for 24 months post-closing. The Sponsor also agreed to provide an unsecured loan (Sponsor PIK Note) if transaction proceeds fall below the Minimum Cash Amount.
- Company Support Agreement: Company Members agreed to vote in favor of the transaction, waive appraisal rights, and adhere to similar lock-up periods (15% for 180 days, 85% for 24 months).
- Registration Rights Agreement: ERES agreed to file a shelf registration statement within 30 days of closing to allow for the resale of shares held by Company Members and other parties.
Conditions, Risks, and Outlook
Conditions to Closing: The transaction is subject to several conditions, including stockholder approval, regulatory approvals (specifically from the Florida Office of Insurance Regulation and California Department of Insurance), expiration of HSR Act waiting periods, and the conversion of the Companies from Florida to Delaware LLCs.
Termination Rights: The agreement may be terminated by mutual consent, by either party if laws prohibit the transaction, or if specific breaches are not cured by the "Outside Date" of January 27, 2023. ERES may terminate if required Company Member approvals are not obtained by August 31, 2022.
Risks and Contingencies: The filing highlights significant risks, including the potential failure to complete the transaction by the business combination deadline, the risk of stockholder redemptions reducing cash below the minimum threshold, regulatory hurdles in the life settlement industry, and uncertainties regarding future financial performance and market demand for life settlements.
Outlook: Management anticipates the transaction will provide a platform for growth in the life settlement market, though the filing explicitly states that forward-looking statements are not guarantees and actual results may differ materially.
Investor Verification Checklist
- Verify the final number of public shares redeemed, as this directly impacts whether the $1,000,000 Minimum Cash Amount and $5,000,001 Net Tangible Asset thresholds are met.
- Confirm receipt of regulatory approvals from the Florida Office of Insurance Regulation and the California Department of Insurance regarding the change of control.
- Review the upcoming Proxy Statement for detailed risk factors and the specific terms of the Sponsor PIK Note.
- Monitor the status of the Company Member approvals, which must be obtained by August 31, 2022, to avoid immediate termination by ERES.
- Assess the potential dilution impact of the $618.0 million equity issuance and the exercise of existing warrants.